Neophytou, C.M., Constantinou C., and Constantinou A.I. (2012). D-alpha-tocopheryl polyethylene glycol succinate (TPGS) induces apoptosis and cell cycle arrest selectively in breast cancer cells by targeting aberrantly activated pathways engaging survivin signaling. Proceedings of the American Assoc. Cancer Res. 53, 1190.

Constantina Constantinou

Neophytou, C.M., Constantinou C., and Constantinou A.I. (2012). D-alpha-tocopheryl polyethylene glycol succinate (TPGS) induces apoptosis and cell cycle arrest selectively in breast cancer cells by targeting aberrantly activated pathways engaging survivin signaling. Proceedings of the American Assoc. Cancer Res. 53, 1190.

Constantina Constantinou

Medical School

Research output: Chapter in Book/Report/Conference proceeding › Conference contribution › peer-review

Original language	English
Title of host publication	Proceedings of the American Association of Cancer Research
Publication status	Published - 2012

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Cite this

Constantinou, C. (2012). Neophytou, C.M., Constantinou C., and Constantinou A.I. (2012). D-alpha-tocopheryl polyethylene glycol succinate (TPGS) induces apoptosis and cell cycle arrest selectively in breast cancer cells by targeting aberrantly activated pathways engaging survivin signaling. Proceedings of the American Assoc. Cancer Res. 53, 1190. In Proceedings of the American Association of Cancer Research

Constantinou, Constantina. / Neophytou, C.M., Constantinou C., and Constantinou A.I. (2012). D-alpha-tocopheryl polyethylene glycol succinate (TPGS) induces apoptosis and cell cycle arrest selectively in breast cancer cells by targeting aberrantly activated pathways engaging survivin signaling. Proceedings of the American Assoc. Cancer Res. 53, 1190. Proceedings of the American Association of Cancer Research. 2012.

@inproceedings{88b28959281845879c6241ad3083f661,

title = "Neophytou, C.M., Constantinou C., and Constantinou A.I. (2012). D-alpha-tocopheryl polyethylene glycol succinate (TPGS) induces apoptosis and cell cycle arrest selectively in breast cancer cells by targeting aberrantly activated pathways engaging survivin signaling. Proceedings of the American Assoc. Cancer Res. 53, 1190.",

author = "Constantina Constantinou",

year = "2012",

language = "English",

booktitle = "Proceedings of the American Association of Cancer Research",

}

Constantinou, C 2012, Neophytou, C.M., Constantinou C., and Constantinou A.I. (2012). D-alpha-tocopheryl polyethylene glycol succinate (TPGS) induces apoptosis and cell cycle arrest selectively in breast cancer cells by targeting aberrantly activated pathways engaging survivin signaling. Proceedings of the American Assoc. Cancer Res. 53, 1190. in Proceedings of the American Association of Cancer Research.

Neophytou, C.M., Constantinou C., and Constantinou A.I. (2012). D-alpha-tocopheryl polyethylene glycol succinate (TPGS) induces apoptosis and cell cycle arrest selectively in breast cancer cells by targeting aberrantly activated pathways engaging survivin signaling. Proceedings of the American Assoc. Cancer Res. 53, 1190. / Constantinou, Constantina.
Proceedings of the American Association of Cancer Research. 2012.

Research output: Chapter in Book/Report/Conference proceeding › Conference contribution › peer-review

TY - GEN

T1 - Neophytou, C.M., Constantinou C., and Constantinou A.I. (2012). D-alpha-tocopheryl polyethylene glycol succinate (TPGS) induces apoptosis and cell cycle arrest selectively in breast cancer cells by targeting aberrantly activated pathways engaging survivin signaling. Proceedings of the American Assoc. Cancer Res. 53, 1190.

AU - Constantinou, Constantina

PY - 2012

Y1 - 2012

M3 - Conference contribution

BT - Proceedings of the American Association of Cancer Research

ER -

Constantinou C. Neophytou, C.M., Constantinou C., and Constantinou A.I. (2012). D-alpha-tocopheryl polyethylene glycol succinate (TPGS) induces apoptosis and cell cycle arrest selectively in breast cancer cells by targeting aberrantly activated pathways engaging survivin signaling. Proceedings of the American Assoc. Cancer Res. 53, 1190. In Proceedings of the American Association of Cancer Research. 2012